Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
EPZM | Epizyme, Inc. | Bogle Grant C. | See Remarks | Aug 09, 2022 | Option Exercise | $1.40 | 2,358,890 | 3,295,109 | 983,060 | Aug 11, 2022, 09:00 PM | |
EPZM | Epizyme, Inc. | Agarwal Shefali | See Remarks | Aug 09, 2022 | Option Exercise | $1.39 | 873,154 | 1,213,684 | 658,716 | Aug 11, 2022, 08:53 PM | |
EPZM | Epizyme, Inc. | Beaulieu Joseph | See Remarks | Aug 09, 2022 | Option Exercise | $1.39 | 579,864 | 806,011 | 330,963 | Aug 11, 2022, 08:53 PM | |
EPZM | Epizyme, Inc. | Kutok Jeffery | Chief Scientific Officer | Aug 09, 2022 | Option Exercise | $1.39 | 734,496 | 1,020,949 | 474,563 | Aug 11, 2022, 08:52 PM | |
EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Jun 30, 2022 | Option Exercise | $1.47 | 16,156 | 23,749 | 224,488 | Jul 05, 2022, 05:06 PM | |
EPZM | Epizyme, Inc. | BEVERIDGE, ROY A | Director | Jun 30, 2022 | Option Exercise | $1.47 | 8,928 | 13,124 | 46,037 | Jul 05, 2022, 05:06 PM | |
EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Jun 30, 2022 | Option Exercise | $1.47 | 10,204 | 15,000 | 62,318 | Jul 05, 2022, 05:02 PM | |
EPZM | Epizyme, Inc. | Kutok Jeffery | Chief Scientific Officer | Apr 11, 2022 | Sale | $0.90 | 2,741 | 2,467 | 94,563 | Apr 13, 2022, 05:49 PM | |
EPZM | Epizyme, Inc. | BEVERIDGE, ROY A | Director | Mar 31, 2022 | Option Exercise | $1.15 | 11,413 | 13,125 | 28,115 | Apr 01, 2022, 05:31 PM | |
EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Mar 31, 2022 | Option Exercise | $1.15 | 20,653 | 23,751 | 199,338 | Apr 01, 2022, 05:30 PM | |
EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Mar 31, 2022 | Option Exercise | $1.15 | 13,043 | 14,999 | 43,120 | Apr 01, 2022, 05:30 PM | |
EPZM | Epizyme, Inc. | Beaulieu Joseph | See Remarks | Feb 28, 2022 | Option Exercise | $1.27 | 2,331 | 2,952 | 30,963 | Mar 21, 2022, 06:06 PM | |
EPZM | Epizyme, Inc. | Agarwal Shefali | See Remarks | Feb 28, 2022 | Option Exercise | $1.27 | 2,331 | 2,952 | 158,716 | Mar 21, 2022, 06:05 PM | |
EPZM | Epizyme, Inc. | Beaulieu Joseph | Corporate Controller | Feb 07, 2022 | Sale | $1.50 | 222 | 333 | 28,632 | Feb 09, 2022, 05:43 PM | |
EPZM | Epizyme, Inc. | Agarwal Shefali | See Remarks | Feb 07, 2022 | Sale | $1.50 | 1,058 | 1,587 | 156,385 | Feb 09, 2022, 05:40 PM | |
EPZM | Epizyme, Inc. | Agarwal Shefali | See Remarks | Feb 02, 2022 | Sale | $1.37 | 2,639 | 3,615 | 157,443 | Feb 04, 2022, 04:15 PM | |
EPZM | Epizyme, Inc. | Kutok Jeffery | Chief Scientific Officer | Feb 02, 2022 | Sale | $1.37 | 2,556 | 3,502 | 97,304 | Feb 04, 2022, 04:15 PM | |
EPZM | Epizyme, Inc. | Beaulieu Joseph | Corporate Controller | Feb 02, 2022 | Sale | $1.37 | 687 | 941 | 28,854 | Feb 04, 2022, 04:15 PM | |
EPZM | Epizyme, Inc. | RPI Finance Trust | 10% Owner | Jan 31, 2022 | Buy | $1.50 | 22,666,667 | 34,000,001 | 31,833,334 | Feb 01, 2022, 04:17 PM | |
EPZM | Epizyme, Inc. | Agarwal Shefali | See Remarks | Jan 26, 2022 | Sale | $2.02 | 2,922 | 5,902 | 160,082 | Jan 28, 2022, 04:15 PM | |
EPZM | Epizyme, Inc. | Agarwal Shefali | See Remarks | Dec 06, 2021 | Sale | $2.93 | 1,780 | 5,215 | 163,004 | Dec 07, 2021, 07:03 PM | |
EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sep 30, 2021 | Option Exercise | $5.12 | 4,640 | 23,757 | 169,185 | Oct 01, 2021, 04:30 PM | |
EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Sep 30, 2021 | Option Exercise | $5.12 | 2,930 | 15,002 | 24,077 | Oct 01, 2021, 04:30 PM | |
EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Jun 30, 2021 | Option Exercise | $8.31 | 1,805 | 15,000 | 21,147 | Jul 01, 2021, 04:15 PM | |
EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Jun 30, 2021 | Option Exercise | $8.31 | 2,858 | 23,750 | 164,545 | Jul 01, 2021, 04:15 PM | |
EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Mar 31, 2021 | Option Exercise | $8.71 | 1,723 | 15,007 | 11,282 | Apr 01, 2021, 07:00 PM | |
EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Mar 31, 2021 | Option Exercise | $8.71 | 2,727 | 23,752 | 153,627 | Apr 01, 2021, 07:00 PM | |
EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Mar 25, 2021 | Buy | $7.98 | 28,231 | 225,283 | 116,414 | Mar 29, 2021, 04:30 PM | |
EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Mar 26, 2021 | Buy | $7.97 | 34,486 | 274,817 | 150,900 | Mar 29, 2021, 04:30 PM | |
EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Mar 25, 2021 | Sale | $7.85 | 10,328 | 81,075 | 322,626 | Mar 29, 2021, 04:30 PM | |
EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Feb 04, 2021 | Sale | $11.21 | 3,890 | 43,607 | 331,977 | Feb 05, 2021, 04:41 PM | |
EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Officer | Feb 04, 2021 | Sale | $11.21 | 969 | 10,862 | 104,341 | Feb 05, 2021, 04:41 PM | |
EPZM | Epizyme, Inc. | TOMBESI PAOLO | Chief Financial Officer | Feb 04, 2021 | Sale | $11.21 | 1,021 | 11,445 | 53,465 | Feb 05, 2021, 04:40 PM | |
EPZM | Epizyme, Inc. | Beaulieu Joseph | Corporate Controller | Feb 04, 2021 | Sale | $11.21 | 227 | 2,545 | 13,431 | Feb 05, 2021, 04:40 PM | |
EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Feb 04, 2021 | Sale | $11.21 | 894 | 10,022 | 83,188 | Feb 05, 2021, 04:36 PM | |
EPZM | Epizyme, Inc. | Vakiener Victoria | Chief Commercial Officer | Feb 04, 2021 | Sale | $11.21 | 817 | 9,159 | 52,685 | Feb 05, 2021, 04:32 PM | |
EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Jan 25, 2021 | Sale | $11.41 | 6,069 | 69,247 | 248,367 | Jan 27, 2021, 08:44 PM | |
EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Jan 25, 2021 | Sale | $11.41 | 2,872 | 32,770 | 55,957 | Jan 27, 2021, 08:42 PM | |
EPZM | Epizyme, Inc. | Vakiener Victoria | Chief Commercial Officer | Jan 25, 2021 | Sale | $11.41 | 599 | 6,835 | 27,982 | Jan 27, 2021, 08:42 PM | |
EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Officer | Jan 25, 2021 | Sale | $11.41 | 2,872 | 32,770 | 75,727 | Jan 27, 2021, 08:38 PM | |
EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Dec 31, 2020 | Option Exercise | $10.86 | 1,024 | 11,121 | 9,559 | Jan 05, 2021, 08:32 AM | |
EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Dec 31, 2020 | Option Exercise | $10.86 | 2,158 | 23,436 | 88,183 | Jan 05, 2021, 08:15 AM | |
EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Officer | Dec 03, 2020 | Sale | $13.54 | 2,522 | 34,148 | 76,089 | Dec 07, 2020, 07:00 AM | |
EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Nov 11, 2020 | Buy | $12.07 | 5,000 | 60,350 | 5,000 | Nov 13, 2020, 07:05 AM | |
EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sep 30, 2020 | Option Exercise | $11.93 | 1,965 | 23,442 | 86,025 | Oct 01, 2020, 04:58 PM | |
EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Sep 30, 2020 | Option Exercise | $11.93 | 933 | 11,131 | 8,535 | Oct 01, 2020, 04:56 PM | |
EPZM | Epizyme, Inc. | Beaulieu Joseph | Corporate Controller | Sep 03, 2019 | Sale | $12.77 | 971 | 12,400 | 6,501 | Sep 03, 2020, 09:30 PM | |
EPZM | Epizyme, Inc. | Beaulieu Joseph | Corporate Controller | Sep 02, 2020 | Sale | $12.88 | 543 | 6,994 | 5,958 | Sep 03, 2020, 09:30 PM | |
EPZM | Epizyme, Inc. | TOMBESI PAOLO | Chief Financial Officer | Aug 20, 2020 | Option Exercise | $12.55 | 2,091 | 26,242 | 26,906 | Aug 21, 2020, 04:15 PM | |
EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Jun 30, 2020 | Option Exercise | $16.06 | 1,459 | 23,432 | 84,060 | Jul 01, 2020, 05:04 PM | |
EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Jun 30, 2020 | Option Exercise | $16.06 | 693 | 11,130 | 7,602 | Jul 01, 2020, 04:32 PM | |
EPZM | Epizyme, Inc. | Beaulieu Joseph | Corporate Controller | Jun 26, 2020 | Sale | $16.15 | 317 | 5,120 | 4,838 | Jun 30, 2020, 09:04 AM | |
EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Jun 26, 2020 | Sale | $16.15 | 4,773 | 77,084 | 250,098 | Jun 30, 2020, 09:01 AM | |
EPZM | Epizyme, Inc. | TOMBESI PAOLO | Chief Financial Officer | Jun 26, 2020 | Sale | $16.15 | 1,805 | 29,151 | 21,942 | Jun 30, 2020, 08:57 AM | |
EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Officer | Jun 26, 2020 | Sale | $16.15 | 1,805 | 29,151 | 78,611 | Jun 30, 2020, 08:56 AM | |
EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Jun 26, 2020 | Sale | $16.15 | 2,728 | 44,057 | 57,507 | Jun 30, 2020, 08:54 AM | |
EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Jun 26, 2020 | Buy | $16.03 | 62,019 | 994,165 | 82,601 | Jun 26, 2020, 07:12 PM | |
EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Jun 18, 2020 | Sale | $17.66 | 30,000 | 529,800 | 264,371 | Jun 22, 2020, 07:36 PM | |
EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Jun 18, 2020 | Sale | $15.35 | 224,006 | 3,439,113 | 120,449 | Jun 22, 2020, 07:31 PM | |
EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Mar 31, 2020 | Option Exercise | $15.51 | 1,512 | 23,451 | 20,582 | Apr 02, 2020, 07:02 PM | |
EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Mar 31, 2020 | Option Exercise | $15.51 | 717 | 11,121 | 6,909 | Apr 02, 2020, 07:00 PM | |
EPZM | Epizyme, Inc. | Beaulieu Joseph | Corporate Controller | Mar 25, 2020 | Sale | $15.28 | 212 | 3,239 | 4,961 | Mar 26, 2020, 09:11 PM | |
EPZM | Epizyme, Inc. | TOMBESI PAOLO | Chief Financial Officer | Mar 25, 2020 | Sale | $15.28 | 1,243 | 18,993 | 15,437 | Mar 26, 2020, 09:01 PM | |
EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Mar 25, 2020 | Sale | $15.28 | 1,243 | 18,993 | 51,798 | Mar 26, 2020, 09:01 PM | |
EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Mar 25, 2020 | Sale | $15.28 | 3,285 | 50,195 | 254,371 | Mar 26, 2020, 09:00 PM | |
EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Officer | Mar 25, 2020 | Sale | $15.28 | 1,243 | 18,993 | 71,991 | Mar 26, 2020, 09:00 PM | |
EPZM | Epizyme, Inc. | Allen Andrew R | Director | Mar 16, 2020 | Option Exercise | $9.33 | 12,500 | 116,625 | 12,500 | Mar 18, 2020, 04:30 PM | |
EPZM | Epizyme, Inc. | Beaulieu Joseph | Corporate Controller | Mar 03, 2020 | Sale | $22.18 | 996 | 22,091 | 3,617 | Mar 05, 2020, 06:52 PM | |
EPZM | Epizyme, Inc. | Legorreta Pablo G. | Director | Feb 11, 2020 | Option Exercise | $20.00 | 2,500,000 | 50,000,000 | 9,166,667 | Feb 13, 2020, 06:47 PM | |
EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Officer | Jan 24, 2020 | Sale | $24.64 | 1,843 | 45,412 | 61,433 | Jan 27, 2020, 09:19 PM | |
EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Officer | Jan 27, 2020 | Sale | $20.44 | 2,630 | 53,757 | 58,803 | Jan 27, 2020, 09:19 PM | |
EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Jan 24, 2020 | Sale | $23.38 | 4,242 | 99,158 | 42,185 | Jan 27, 2020, 09:18 PM | |
EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Jan 24, 2020 | Sale | $24.62 | 3,002 | 73,909 | 90,742 | Jan 27, 2020, 09:17 PM | |
EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Jan 27, 2020 | Sale | $20.44 | 6,074 | 124,153 | 84,668 | Jan 27, 2020, 09:17 PM | |
EPZM | Epizyme, Inc. | Beaulieu Joseph | Corporate Controller | Jan 24, 2020 | Sale | $24.63 | 330 | 8,128 | 1,042 | Jan 27, 2020, 09:16 PM | |
EPZM | Epizyme, Inc. | TOMBESI PAOLO | Chief Financial Officer | Jan 23, 2020 | Option Exercise | $26.72 | 1,698 | 45,371 | 3,302 | Jan 27, 2020, 09:15 PM | |
EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Dec 31, 2019 | Option Exercise | $24.60 | 952 | 23,419 | 19,070 | Jan 03, 2020, 04:44 PM | |
EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Dec 31, 2019 | Option Exercise | $24.60 | 452 | 11,119 | 6,192 | Jan 03, 2020, 04:33 PM | |
EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sep 30, 2019 | Option Exercise | $10.32 | 2,271 | 23,437 | 18,118 | Oct 02, 2019, 04:54 PM | |
EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Sep 30, 2019 | Option Exercise | $10.32 | 1,078 | 11,125 | 5,740 | Oct 02, 2019, 04:15 PM | |
EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Jun 30, 2019 | Option Exercise | $12.55 | 1,868 | 23,443 | 15,847 | Jul 02, 2019, 04:28 PM | |
EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Jun 30, 2019 | Option Exercise | $12.55 | 887 | 11,132 | 4,662 | Jul 02, 2019, 12:00 AM | |
EPZM | Epizyme, Inc. | SEIDENBERG BETH C | Director | Jun 30, 2019 | Option Exercise | $12.55 | 1,010 | 12,676 | 8,481 | Jul 02, 2019, 12:00 AM | |
EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Jun 27, 2019 | Sale | $12.43 | 52,473 | 652,134 | 0 | Jun 28, 2019, 07:05 PM | |
EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Jun 26, 2019 | Sale | $12.85 | 52,472 | 674,176 | 52,473 | Jun 26, 2019, 05:16 PM | |
EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Jun 25, 2019 | Sale | $13.31 | 52,472 | 698,649 | 104,945 | Jun 26, 2019, 05:16 PM | |
EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Officer | Jun 14, 2019 | Sale | $11.97 | 1,195 | 14,304 | 35,699 | Jun 17, 2019, 05:18 PM | |
EPZM | Epizyme, Inc. | Beaulieu Joseph | Corporate Controller | Jun 13, 2019 | Sale | $12.10 | 203 | 2,456 | 497 | Jun 14, 2019, 06:56 PM | |
EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Jun 13, 2019 | Sale | $12.10 | 1,185 | 14,339 | 39,032 | Jun 14, 2019, 06:54 PM | |
EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Jun 13, 2019 | Sale | $12.10 | 2,074 | 25,095 | 84,994 | Jun 14, 2019, 06:53 PM | |
EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Mar 31, 2019 | Option Exercise | $12.39 | 1,891 | 23,429 | 13,979 | Jun 07, 2019, 04:44 PM | |
EPZM | Epizyme, Inc. | SEIDENBERG BETH C | Director | Mar 31, 2019 | Option Exercise | $12.39 | 1,024 | 12,687 | 7,471 | Jun 07, 2019, 04:29 PM | |
EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Mar 31, 2019 | Option Exercise | $12.39 | 897 | 11,114 | 3,775 | Jun 07, 2019, 04:25 PM | |
EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Oct 05, 2018 | Buy | $9.00 | 416,667 | 3,750,003 | 6,471,018 | Oct 05, 2018, 06:36 PM | |
EPZM | Epizyme, Inc. | SEIDENBERG BETH C | Director | Jul 02, 2018 | Option Exercise | $13.55 | 3,247 | 43,997 | 6,447 | Jul 02, 2018, 05:42 PM | |
EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Jul 02, 2018 | Option Exercise | $13.55 | 6,088 | 82,492 | 12,088 | Jul 02, 2018, 05:37 PM | |
EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Jul 02, 2018 | Option Exercise | $13.55 | 2,878 | 38,997 | 2,878 | Jul 02, 2018, 05:34 PM | |
EPZM | Epizyme, Inc. | Ros Matthew | Chief Operating Officer | Feb 05, 2018 | Sale | $13.10 | 144,528 | 1,893,984 | 74,867 | Feb 06, 2018, 04:26 PM | |
EPZM | Epizyme, Inc. | Ho Peter Tai-Ching | Chief Development Officer | Oct 24, 2017 | Sale | $12.71 | 30,000 | 381,291 | 23,123 | Oct 25, 2017, 12:29 PM | |
EPZM | Epizyme, Inc. | Ho Peter Tai-Ching | Chief Development Officer | Sep 25, 2017 | Option Exercise | $12.89 | 30,000 | 386,776 | 23,123 | Sep 26, 2017, 04:46 PM |